サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390679

計算生物学市場レポート：用途、サービス、最終用途、地域別、2023年～2028年

Computational Biology Market Report by Application, Services, End Use, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
計算生物学市場レポート：用途、サービス、最終用途、地域別、2023年～2028年
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の計算生物学市場規模は2022年に47億米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに152億4,000万米ドルに達し、2022年～2028年の成長率（CAGR）は21.66%に達すると予測しています。

バイオインフォマティクスとしても知られる計算生物学は、数学、統計学、コンピュータサイエンスを用いて生命の構造とプロセスを理解しモデル化する学際的な科学の一分野です。遺伝学、進化学、細胞生物学、生化学など、生物学の様々な側面に関わる。その過程では、アルゴリズムなどの計算技術を駆使して、生物学的システムを表現・シミュレーションし、実験データを大規模に解釈します。計算生物学はまた、アミノ酸配列、ヌクレオチド、高分子構造から生物学的情報のデータベースを作成することにより、病気の治療法や細胞機能の理解にも役立ちます。現在、計算生物学は、ヒトゲノムプロジェクト、タンパク質データバンク、ゲノムデータベースなど、生物学研究プロジェクトに欠かせないものとなっています。

計算生物学の市場動向：

世界の計算生物学市場は、主に薬理ゲノミクス分野における臨床研究の増加によって牽引されています。これにより、患者集団の多様な生物学的構成、生物学的経路、それらを支えるゲノムについての理解が深まっています。その結果、創薬やその他のさまざまな科学実験に要する時間全体の短縮に役立つ計算生物学ソリューションに対する需要が高まっています。このプロセスは、高度な薬物-薬物相互作用をシミュレートするツールの視覚化にも役立っています。これに加えて、タンパク質の構造や相互作用を解明するためのエピゲノミクス、プロテオミクス、メタゲノミクスにおける計算生物学の需要の高まりも、市場の成長を後押ししています。さらに、医薬品開発や疾患モデリングにおける様々な技術的進歩や、民間および政府機関による研究開発（R&D）活動への投資の増加も、近い将来、市場にプラスの推進力を与えると予測されます。

本レポートで扱う主な質問

  • 2022年の計算生物学の世界市場規模は？
  • 2023年～2028年の世界の計算生物学市場の予想成長率は？
  • 世界の計算生物学市場を牽引する主要因は何か？
  • COVID-19が世界の計算生物学市場に与えた影響は？
  • 世界の計算生物学市場の用途別区分は？
  • サービス別の計算生物学世界市場の内訳は？
  • 計算生物学の世界市場の最終用途に基づく区分は？
  • 計算生物学の世界市場における主要地域は？
  • 計算生物学の世界市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の計算生物学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用途別

  • 細胞・生体シミュレーション
    • 市場動向
    • 主要セグメント
      • コンピューテーショナルゲノミクス
      • 計算プロテオミクス
      • ファーマコゲノミクス
      • その他
    • 市場予測
  • 創薬と疾患モデリング
    • 市場動向
    • 主要セグメント
      • ターゲット同定
      • ターゲットの検証
      • リード探索
      • リードの最適化
    • 市場予測
  • 前臨床医薬品開発
    • 市場動向
    • 主要セグメント
      • 薬物動態学
      • 薬力学
    • 市場予測
  • 臨床試験
    • 市場動向
    • 主要セグメント
      • 第I相
      • フェーズII
      • フェーズIII
    • 市場予測
  • 人体シミュレーションソフトウェア
    • 市場動向
    • 市場予測

第7章 市場内訳：サービス別

  • インハウス
    • 市場動向
    • 市場予測
  • コントラクト
    • 市場動向
    • 市場予測

第8章 市場内訳：最終用途別

  • 学術
    • 市場動向
    • 市場予測
  • 製薬
    • 市場動向
    • 市場予測
  • 商業
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Certara
    • Chemical Computing Group ULC
    • Compugen Ltd
    • Dassault Systemes
    • Genedata AG
    • Insilico Biotechnology AG
    • Instem plc
    • Nimbus Therapeutics LLC
    • Schrodinger Inc.
    • Simulations Plus Inc.
図表

List of Figures

  • Figure 1: Global: Computational Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Computational Biology Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Computational Biology Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Computational Biology Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Computational Biology Market: Breakup by Services (in %), 2022
  • Figure 6: Global: Computational Biology Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Computational Biology Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Computational Biology (Cellular and Biological Simulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Computational Biology (Cellular and Biological Simulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Computational Biology (Drug Discovery and Disease Modelling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Computational Biology (Drug Discovery and Disease Modelling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Computational Biology (Preclinical Drug Development) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Computational Biology (Preclinical Drug Development) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Computational Biology (Clinical Trials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Computational Biology (Clinical Trials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Computational Biology (Human Body Simulation Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Computational Biology (Human Body Simulation Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Computational Biology (In-house) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Computational Biology (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Computational Biology (Contract) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Computational Biology (Contract) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Computational Biology (Academics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Computational Biology (Academics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Computational Biology (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Computational Biology (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Computational Biology (Commercial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Computational Biology (Commercial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Computational Biology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Computational Biology Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Computational Biology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Computational Biology Industry: SWOT Analysis
  • Figure 78: Global: Computational Biology Industry: Value Chain Analysis
  • Figure 79: Global: Computational Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Computational Biology Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Computational Biology Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Computational Biology Market Forecast: Breakup by Services (in Million US$), 2023-2028
  • Table 4: Global: Computational Biology Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Computational Biology Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Computational Biology Market: Competitive Structure
  • Table 7: Global: Computational Biology Market: Key Players
目次
Product Code: SR112023A4495

Abstract

The global computational biology market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.24 Billion by 2028, exhibiting a growth rate (CAGR) of 21.66% during 2022-2028.

Computational biology, also known as bioinformatics, is the interdisciplinary branch of science that uses math, statistics and computer science for understanding and modeling the structures and processes of life. It involves various aspects of biology, such as genetics, evolution, cell biology, and biochemistry. The process uses computational techniques, including algorithms, to represent and simulate biological systems and interpret experimental data on a large scale. Computational biology also helps understand the treatment for diseases and cellular function by creating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures. Nowadays, computational biology has become an essential part of biological research projects, including the human genome project, protein data banks and genomic databases.

Computational Biology Market Trends:

The global computational biology market is primarily driven by the rising number of clinical studies in the field of pharmacogenomics. This has helped increase the understanding of the diverse biological makeup of the patient population, biological pathways, and the genomes underpinning them. As a result, there is a high demand for computational biology solutions, as they help reduce the overall time needed for drug discovery and various other scientific experiments. The process also aids the visualization of tools to simulate advanced drug-drug interactions. In addition to this, the growing demand for computational biology in epi-genomics, proteomics, and meta-genomics to undertint protein structures and interactions is also propelling the market growth. Furthermore, various technological advancements in drug development and disease modeling, along with increasing investments by private and government organizations in research and development (R&D) activities, are also anticipated to provide a positive thrust to the market in the near future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global computational biology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application, services and end use.

Breakup by Application:

Cellular and Biological Simulation

Computational Genomics

Computational Proteomics

Pharmacogenomics

Others

Drug Discovery and Disease Modelling

Target Identification

Target Validation

Lead Discovery

Lead Optimization

Preclinical Drug Development

Pharmacokinetics

Pharmacodynamics

Clinical Trials

Phase I

Phase II

Phase III

Human Body Simulation Software

Breakup by Services:

In-house

Contract

Breakup by End Use:

Academics

Pharmaceutical Industry

Commercial

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systemes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrodinger Inc. and Simulations Plus Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global computational biology market in 2022?
  • 2. What is the expected growth rate of the global computational biology market during 2023-2028?
  • 3. What are the key factors driving the global computational biology market?
  • 4. What has been the impact of COVID-19 on the global computational biology market?
  • 5. What is the breakup of the global computational biology market based on the application?
  • 6. What is the breakup of the global computational biology market based on the services?
  • 7. What is the breakup of the global computational biology market based on the end use?
  • 8. What are the key regions in the global computational biology market?
  • 9. Who are the key players/companies in the global computational biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Computational Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Cellular and Biological Simulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computational Genomics
      • 6.1.2.2 Computational Proteomics
      • 6.1.2.3 Pharmacogenomics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Drug Discovery and Disease Modelling
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Target Identification
      • 6.2.2.2 Target Validation
      • 6.2.2.3 Lead Discovery
      • 6.2.2.4 Lead Optimization
    • 6.2.3 Market Forecast
  • 6.3 Preclinical Drug Development
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Pharmacodynamics
    • 6.3.3 Market Forecast
  • 6.4 Clinical Trials
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Phase I
      • 6.4.2.2 Phase II
      • 6.4.2.3 Phase III
    • 6.4.3 Market Forecast
  • 6.5 Human Body Simulation Software
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Services

  • 7.1 In-house
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Contract
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Academics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Commercial
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Certara
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Chemical Computing Group ULC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Compugen Ltd
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Dassault Systemes
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genedata AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Insilico Biotechnology AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Instem plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Nimbus Therapeutics LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Schrodinger Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Simulations Plus Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials